CD8A and neoplasm: Importantly, anti-tumor lymphocytes, CD4+ and CD8+ T-cells, were decreased in LvMs and NLvMs compared to BrT but increased in AxMs and NAxLNMs (Figs. 3c, 3b, 5a, Table 2).